{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:02:16Z","timestamp":1785391336421,"version":"3.55.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the prognostic value of preoperative and postoperative modified Gustave Roussy Immune Score (mGRIm) and dynamic mGRIm trajectories in patients with colorectal cancer (CRC), and to develop internally validated machine-learning models based on perioperative dynamic features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 457 patients with CRC who underwent primary tumor resection at Hubei Cancer Hospital between January 2016 and December 2019. Preoperative and postoperative mGRIm scores were calculated using receiver operating characteristic curve-derived cut-off values for albumin, lactate dehydrogenase, and neutrophil-to-lymphocyte ratio. Dynamic mGRIm trajectory was defined as the transition between preoperative and postoperative mGRIm risk states. Associations with overall survival (OS) and disease-free survival (DFS) were evaluated using Kaplan\u2013Meier analysis and Cox proportional hazards models. Machine-learning model development incorporated Boruta-based feature selection, training set\u2013restricted 5-fold cross-validation, and training set\u2013restricted resampling strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Dynamic mGRIm trajectory showed strong and consistent prognostic stratification. Patients with persistently high mGRIm status had significantly higher risks of death (HR = 3.47, 95% CI: 1.76 -6.83, p &amp;lt; 0.001) and DFS events (HR = 2.76, 95% CI: 1.65 -4.61, p &amp;lt; 0.001) than those with persistently low status. In the prespecified evaluation framework integrating multiple performance metrics, the neural network model achieved the highest composite score for OS prediction (AUC\u00a0=\u00a00.801), whereas the radial basis function support vector machine achieved the best performance for DFS prediction (AUC\u00a0=\u00a00.856) in the independent test set.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Dynamic mGRIm trajectory provides robust prognostic information for patients with CRC. Machine-learning models based on perioperative dynamic features demonstrate satisfactory internal predictive performance; however, external validation is required prior to clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1761650","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:39:24Z","timestamp":1785389964000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction of prognostic models for colorectal cancer based on the perioperative modified Gustave Roussy Immune Score and machine learning"],"prefix":"10.3389","volume":"17","author":[{"given":"Jie","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"Department of Gastrointestinal Oncology Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhong","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Oncology Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, Hubei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShuaiJin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)01221-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21858","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019","volume":"74","author":"Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejca.2017.10.028","article-title":"Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3","volume":"88","author":"Modest","year":"2018","journal-title":"Eur J Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.annonc.2019.10.007","article-title":"Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives","volume":"31","author":"Martinelli","year":"2020","journal-title":"Ann Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00569-4","article-title":"Optimizing immunotherapy for colorectal cancer","volume":"19","author":"Ganesh","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-5-63","article-title":"Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy","volume":"5","author":"Sun","year":"2012","journal-title":"J Hematol Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6462-1","article-title":"AJCC 8th edition: Colorectal cancer","volume":"25","author":"Weiser","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2018.03.052","article-title":"Geriatric nutritional risk index as a prognostic factor in patients with esophageal squamous cell carcinoma -retrospective cohort study","volume":"56","author":"Yamana","year":"2018","journal-title":"Int J Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02814-4","article-title":"Prognostic value of post-operative iron biomarkers in colorectal cancer: population-based patient cohort","volume":"131","author":"Gwenzi","year":"2024","journal-title":"Br J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac235","article-title":"Comparison of four clinical prognostic scores in patients with advanced gastric and esophageal cancer","volume":"28","author":"Ma","year":"2023","journal-title":"Oncologist"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.819985","article-title":"Development and validation of a prognostic score for hepatocellular carcinoma patients in immune checkpoint inhibitors therapies: The hepatocellular carcinoma modified Gustave Roussy immune score","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5294","article-title":"The hepatocellular carcinoma modified Gustave Roussy immune score (HCC-GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis","volume":"12","author":"Hatanaka","year":"2023","journal-title":"Cancer Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00432-024-05771-w","article-title":"Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy immune score (mGRIm-s) as a clinico-immunological tool","volume":"150","author":"Ma","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-024-02563-7","article-title":"Gustave Roussy immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study","volume":"29","author":"Tanabe","year":"2024","journal-title":"Int J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110773","article-title":"Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy","volume":"123","author":"Shi","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12226-4","article-title":"Changes in the Gustave Roussy immune score as a powerful prognostic marker of the therapeutic sensitivity of nivolumab in advanced gastric cancer: A multicenter, retrospective study","volume":"29","author":"Nakazawa","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature selection with the Boruta package","volume":"36","author":"Kursa","year":"2010","journal-title":"J Stat Software"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1201\/9780429246593","article-title":"An introduction to the bootstrap","volume":"57","author":"Tibshirani","year":"1993","journal-title":"Monogr Stat Appl Probability"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J Stat Software"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-16399-0","volume-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating","author":"Steyerberg","year":"2019"},{"key":"B22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijsu.2019.08.006","article-title":"Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database","volume":"69","author":"Abu-Talib","year":"2019","journal-title":"Int J Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/ans.15480","article-title":"Novel systemic inflammation response index to predict prognosis after thoracoscopic lung cancer surgery: a propensity score-matching study","volume":"89","author":"Li","year":"2019","journal-title":"Anz J Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1209056","article-title":"Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijsu.2020.10.015","article-title":"Gustave Roussy immune score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study","volume":"84","author":"Li","year":"2020","journal-title":"Int J Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.737283","article-title":"Gustave Roussy immune score as a novel prognostic scoring system for colorectal cancer patients: A propensity score matching analysis","volume":"11","author":"Tian","year":"2021","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/jca.37898","article-title":"Gustave Roussy immune score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma","volume":"11","author":"Feng","year":"2020","journal-title":"J Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.3390\/ijms23147859","article-title":"NK cells and other cytotoxic innate lymphocytes in colorectal cancer progression and metastasis","volume":"23","author":"Fionda","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.01.002","article-title":"The regulation of lymphocyte activation and proliferation","volume":"51","author":"Heinzel","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-016-1433-2","article-title":"The impact of the preoperative peripheral lymphocyte count and lymphocyte percentage in patients with colorectal cancer","volume":"47","author":"Iseki","year":"2017","journal-title":"Surg Today"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188762","article-title":"Tumor-associated neutrophils and neutrophil-targeted cancer therapies","volume":"1877","author":"Que","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05400-x","article-title":"Liver tumour immune microenvironment subtypes and neutrophil heterogeneity","volume":"612","author":"Xue","year":"2022","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.61","article-title":"Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer","volume":"112","author":"Chen","year":"2015","journal-title":"Br J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28536","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis","volume":"134","author":"Li","year":"2014","journal-title":"Int J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4143","article-title":"The prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio (NLR) in colorectal cancer: A systematic review and meta-analysis","volume":"10","author":"Naszai","year":"2021","journal-title":"Cancer Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-11-1457","article-title":"Lactate: a metabolic key player in cancer","volume":"71","author":"Hirschhaeuser","year":"2011","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-014-0260-5","article-title":"Serum lactate dehydrogenase alone is not a helpful prognostic factor in resected colorectal cancer patients","volume":"66","author":"Caputo","year":"2014","journal-title":"Updates Surg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.33160\/yam.2018.03.010","article-title":"Postoperative serum albumin is a potential prognostic factor for older patients with gastric cancer","volume":"61","author":"Saito","year":"2018","journal-title":"Yonago Acta Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/nu10010069","article-title":"Malnutrition, inflammation, atherosclerosis syndrome (MIA) and diet recommendations among end-stage renal disease patients treated with maintenance hemodialysis","volume":"10","author":"Maraj","year":"2018","journal-title":"Nutrients"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5204-5","article-title":"Postoperative systemic inflammatory response, complication severity, and survival following surgery for colorectal cancer","volume":"23","author":"McSorley","year":"2016","journal-title":"Ann Surg Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1761650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:39:26Z","timestamp":1785389966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1761650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2026.1761650"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1761650","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1761650"}}